Skip to Content

213 Results Found

  • Article
  • Open Access
11 Citations
3,136 Views
17 Pages

High Prognostic Value of 68Ga-PSMA PET/CT in Renal Cell Carcinoma and Association with PSMA Expression Assessed by Immunohistochemistry

  • Donatello Gasparro,
  • Maura Scarlattei,
  • Enrico Maria Silini,
  • Silvia Migliari and ,
  • Giorgio Baldari,
  • Veronica Cervati,
  • Tiziano Graziani,
  • Nicoletta Campanini,
  • Umberto Maestroni and
  • Livia Ruffini
  • + 5 authors+ 0 author

28 September 2023

In oligo-metastatic renal cell carcinoma (RCC), neither computed tomography (CT) nor bone scan is sensitive enough to detect small tumor deposits hampering early treatment and potential cure. Prostate-specific membrane antigen (PSMA) is a transmembra...

(This article belongs to the Collection Advances in Cancer Imaging)
  • Article
  • Open Access
6 Citations
2,987 Views
10 Pages

Assessment of PSMA Expression of Healthy Organs in Different Stages of Prostate Cancer Using [68Ga]Ga-PSMA-11-PET Examinations

  • Holger Einspieler,
  • Kilian Kluge,
  • David Haberl,
  • Katrin Schatz and ,
  • Lukas Nics,
  • Stefan Schmitl,
  • Barbara Katharina Geist,
  • Clemens P. Spielvogel,
  • Bernhard Grubmüller and
  • Sazan Rasul
  • + 9 authors+ 4 authors

16 April 2024

The efficacy of radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA) is currently being investigated for its application in patients with early-stage prostate cancer (PCa). However, little is known about PSMA expression in he...

(This article belongs to the Section Methods and Technologies Development)
  • Article
  • Open Access
17 Citations
3,881 Views
12 Pages

PSMA Expression in 122 Treatment Naive Glioma Patients Related to Tumor Metabolism in 11C-Methionine PET and Survival

  • Tatjana Traub-Weidinger,
  • Nina Poetsch,
  • Adelheid Woehrer,
  • Eva-Maria Klebermass and ,
  • Tatjana Bachnik,
  • Matthias Preusser,
  • Mario Mischkulnig,
  • Barbara Kiesel,
  • Georg Widhalm and
  • Oskar Koperek
  • + 7 authors+ 2 authors

30 June 2021

Apart from its expression in benign and malignant prostate tissue, prostate specific membrane antigen (PSMA) was shown to be expressed specifically in the neovasculature of solid tumors. For gliomas only little information exists. Therefore, we aimed...

(This article belongs to the Special Issue The Application of Medical Imaging in Brain Tumors)
  • Communication
  • Open Access
58 Citations
10,184 Views
12 Pages

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer

  • Magdalena Staniszewska,
  • Pedro Fragoso Costa,
  • Matthias Eiber,
  • Jasmin M. Klose and ,
  • Jasmin Wosniack,
  • Henning Reis,
  • Tibor Szarvas,
  • Boris Hadaschik,
  • Katharina Lückerath and
  • Janette Iking
  • + 7 authors+ 2 authors

Prostate-specific membrane antigen (PSMA)-directed radioligand therapy (RLT) prolongs overall survival in men with metastatic castration-resistant prostate cancer (mCRPC). However, men with low PSMA expression are excluded from RLT. We explored the e...

(This article belongs to the Special Issue PSMA in Prostate Cancer)
  • Communication
  • Open Access
7 Citations
3,410 Views
8 Pages

PSMA Expression Correlates with Improved Overall Survival and VEGF Expression in Glioblastoma

  • Alexander Yuile,
  • Adrian Lee,
  • Elizabeth A. Moon,
  • Amanda Hudson and ,
  • Marina Kastelan,
  • Samuel Miller,
  • David Chan,
  • Joe Wei,
  • Michael F. Back and
  • Helen R. Wheeler
  • + 5 authors+ 0 author

Background: Glioblastomas are the most common and fatal primary brain malignancy in adults. There is a growing interest in identifying the molecular mechanisms of these tumors to develop novel treatments. Glioblastoma neo-angiogenesis is driven by VE...

(This article belongs to the Special Issue Gliomas: Signaling Pathways, Molecular Mechanisms and Therapeutic Approaches)
  • Interesting Images
  • Open Access
2 Citations
2,284 Views
3 Pages

PSMA-Positive Follicular Thyroid Carcinoma Incidentally Detected by [68Ga]Ga-PSMA-11 PET/CT: Correlation with Immunohistology Confirms Neovascular PSMA-Expression

  • Florian Rosar,
  • Caroline Burgard,
  • Christian Neubert,
  • Phillip R. Stahl and ,
  • Fadi Khreish and
  • Samer Ezziddin
  • + 1 author+ 0 author

We present an interesting image of an intense PSMA-positive follicular thyroid carcinoma incidentally detected by [68Ga]Ga-PSMA-11 PET/CT in a 76-year-old man with biochemical recurrence of prostate cancer. Immunohistochemical staining demonstrated P...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Article
  • Open Access
39 Citations
5,233 Views
11 Pages

Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC

  • Florian Rosar,
  • Robert Neher,
  • Caroline Burgard,
  • Johannes Linxweiler and ,
  • Mathias Schreckenberger,
  • Manuela A. Hoffmann,
  • Mark Bartholomä,
  • Fadi Khreish and
  • Samer Ezziddin
  • + 4 authors+ 0 author

26 March 2022

In this study, we investigated upregulation of prostate-specific membrane antigen (PSMA) by enzalutamide in a cohort (n = 30) of patients with advanced metastatic castration-resistant prostate cancer (mCRPC). Patients were examined by [68Ga]Ga-PSMA-1...

(This article belongs to the Special Issue Radionuclide Therapy and Hybrid Imaging in Oncology)
  • Brief Report
  • Open Access
5 Citations
5,241 Views
9 Pages

Up-Regulation of PSMA Expression In Vitro as Potential Application in Prostate Cancer Therapy

  • Roswitha Runge,
  • Anne Naumann,
  • Matthias Miederer,
  • Joerg Kotzerke and
  • Claudia Brogsitter

Possibilities to improve the therapeutic efficacy of Lu-177–PSMA-617 radionuclide therapy by modulation of target expression are being investigated. Knowledge on regulatory factors that promote prostate cancer (PCa) progression may contribute t...

(This article belongs to the Special Issue Epigenetics as a Therapeutic Target in Human Diseases)
  • Interesting Images
  • Open Access
3 Citations
2,631 Views
3 Pages

Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on 18F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression

  • Lena M. Mittlmeier,
  • Stephan T. Ledderose,
  • Melanie Schott,
  • Matthias Brendel and ,
  • Leonie Beyer,
  • Sebastian Theurich,
  • Doris Mayr,
  • Christoph Walz,
  • Wolfgang G. Kunz and
  • Marcus Unterrainer
  • + 9 authors+ 4 authors

We present a 71-year-old female patient who underwent 18F-PSMA-1007 PET/CT for suspected metastatic renal cell carcinoma (RCC), as RCC also shows high PSMA-expression in tumor neovascularization. 18F-PSMA-1007 PET/CT showed a high PSMA-avidity in the...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Article
  • Open Access
37 Citations
4,849 Views
14 Pages

11 June 2021

177Lu-Prostate-specific membrane antigen (PSMA)-radioligand therapy (RLT) is a promising treatment option in patients with metastatic castration-resistant prostate cancer (mCRPC). We aimed to determine the predictive value of pretherapeutic PSMA-liga...

(This article belongs to the Special Issue Molecular Imaging and Radio-Nuclide Therapy in Cancers)
  • Review
  • Open Access
61 Citations
9,306 Views
20 Pages

PSMA Expression in Solid Tumors beyond the Prostate Gland: Ready for Theranostic Applications?

  • Chiara Lauri,
  • Lorenzo Chiurchioni,
  • Vincenzo Marcello Russo,
  • Luca Zannini and
  • Alberto Signore

7 November 2022

In the past decades, the expanding use of prostate-specific membrane antigen (PSMA) imaging for prostate cancer has led to the incidental detection of a lot of extra-prostatic malignancies showing an increased uptake of PSMA. Due to these incidental...

(This article belongs to the Special Issue 10th Anniversary of JCM - Nuclear Medicine & Radiology)
  • Article
  • Open Access
33 Citations
5,109 Views
13 Pages

Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging

  • Luigia Vetrone,
  • Riccardo Mei,
  • Lorenzo Bianchi,
  • Francesca Giunchi and ,
  • Andrea Farolfi,
  • Paolo Castellucci,
  • Matteo Droghetti,
  • Massimiliano Presutti,
  • Alessio Degiovanni and
  • Stefano Fanti
  • + 8 authors+ 3 authors

10 March 2023

PSMA-PET/CT is a suitable replacement for conventional imaging in the primary staging of PCa. The aim of this retrospective study was to assess the correlation between parameters discovered by PSMA PET/CT in primary staging and either prostate histop...

(This article belongs to the Special Issue PET/CT in Prostate Cancer)
  • Article
  • Open Access
14 Citations
4,669 Views
15 Pages

Investigation of Prognostic Value of Claudin-5, PSMA, and Ki67 Expression in Canine Splenic Hemangiosarcoma

  • Juliana Moreira Rozolen,
  • Tamires Goneli Wichert Teodoro,
  • Renata Afonso Sobral,
  • Felipe Augusto Ruiz Sueiro and ,
  • Renee Laufer-Amorim,
  • Fabiana Elias and
  • Carlos Eduardo Fonseca-Alves
  • + 2 authors+ 0 author

14 August 2021

Splenic hemangiosarcoma (HSA) is a malignant tumor of endothelial cells that affects middle-aged and elderly dogs and is characterized by the formation of new blood vessels, commonly associated with necrotic and hemorrhagic areas. Despite its importa...

(This article belongs to the Special Issue Canine and Feline Tumors: Research Advances and Diagnostic Innovations)
  • Article
  • Open Access
10 Citations
3,540 Views
13 Pages

Evaluation of Prostate-Specific Membrane Antigen (PSMA) Immunohistochemical Expression in Early-Stage Breast Cancer Subtypes

  • Natalia Andryszak,
  • Paweł Kurzawa,
  • Monika Krzyżaniak,
  • Michał Nowicki and ,
  • Marek Ruchała,
  • Dariusz Iżycki and
  • Rafał Czepczyński
  • + 2 authors+ 0 author

Breast cancer, known for its diverse subtypes, ranks as one of the leading causes of cancer-related deaths. Prostate-specific membrane antigen (PSMA), primarily associated with prostate cancer, has also been identified in breast cancer, though its ro...

(This article belongs to the Special Issue Exploring Therapeutic Targets in the Evolving Landscape of Cancer Immunotherapy)
  • Article
  • Open Access
7 Citations
3,569 Views
13 Pages

PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic Approaches

  • Vinh Ngoc Bui,
  • Lena M. Unterrainer,
  • Matthias Brendel,
  • Sophie C. Kunte and ,
  • Adrien Holzgreve,
  • Fabian Allmendinger,
  • Peter Bartenstein,
  • Frederick Klauschen,
  • Marcus Unterrainer and
  • Stephan Ledderose
  • + 6 authors+ 1 author

20 November 2023

In renal cell carcinoma (RCC), accurate imaging methods are required for treatment planning and response assessment to therapy. In addition, there is an urgent need for new therapeutic options, especially in metastatic RCC. One way to combine diagnos...

(This article belongs to the Special Issue State of the Art and Future Perspectives in Oncologic Imaging)
  • Article
  • Open Access
12 Citations
3,562 Views
9 Pages

Prostate-Specific Membrane Antigen (PSMA) Expression in Tumor-Associated Neovasculature Is an Independent Prognostic Marker in Patients with Ovarian Cancer

  • Gerda Hofstetter,
  • Christina Grech,
  • Dietmar Pils,
  • Johannes Pammer and ,
  • Barbara Neudert,
  • Nina Pötsch,
  • Pascal Baltzer,
  • Tatjana Traub-Weidinger,
  • Veronika Seebacher and
  • Stefanie Aust
  • + 5 authors+ 0 author

31 March 2022

Prostate-specific membrane antigen (PSMA) is present in the tumor-associated neovasculature of many cancer types. Current data in ovarian cancer are limited and controversial; thus, the aim of this study was to investigate PSMA expression in a larger...

(This article belongs to the Special Issue Novel and Personalized Treatment Concepts in Gynecologic Cancer)
  • Article
  • Open Access
1,545 Views
15 Pages

Prostate-Specific Membrane Antigen (PSMA): A Potential Theranostic Biomarker in Breast Cancer

  • Alessandra Virga,
  • Flavia Foca,
  • Stefania Cortecchia,
  • Francesca Poli and ,
  • Paola Caroli,
  • Federica Matteucci,
  • Roberta Maltoni,
  • Massimiliano Mazza,
  • Fabio Nicolini and
  • Sara Bravaccini
  • + 8 authors+ 3 authors

Background: Subtype classification for breast cancer (BC) patients is important for risk-stratification. Unfortunately, this parameter is not always able to discriminate between high- and low-risk diseases. Glutamate Carboxypeptidase-II (GCPII), also...

(This article belongs to the Section Cancer Biology and Oncology)
  • Article
  • Open Access
5 Citations
5,336 Views
13 Pages

Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance

  • Elham Ahmadi,
  • Simon Wang,
  • Mohammad Gouran-Savadkoohi,
  • Georgia Douvi and ,
  • Naghmeh Isfahanian,
  • Nicole Tsakiridis,
  • Brent E. Faught,
  • Jean-Claude Cutz,
  • Monalisa Sur and
  • Theodoros Tsakiridis
  • + 9 authors+ 4 authors

7 November 2023

Metabolic dysregulation is an early event in carcinogenesis. Here, we examined the expression of enzymes involved in de novo lipogenesis (ATP-citrate lyase: ACLY), glucose uptake (Glucose Transporter 1: GLUT1), and folate–glutamate metabolism (...

(This article belongs to the Special Issue Novel Researches and Perspectives on Prostate Cancer)
  • Article
  • Open Access
11 Citations
4,528 Views
13 Pages

Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [68Ga]Ga-RM2—A Head-to-Head Pilot Comparison with [68Ga]Ga-PSMA-11

  • René Fernández,
  • Cristian Soza-Ried,
  • Andrei Iagaru,
  • Andrew Stephens and ,
  • Andre Müller,
  • Hanno Schieferstein,
  • Camilo Sandoval,
  • Horacio Amaral and
  • Vasko Kramer
  • + 4 authors+ 0 author

29 December 2023

Background: The gastrin-releasing peptide receptor (GRPr) is highly overexpressed in several solid tumors, including treatment-naïve and recurrent prostate cancer. [68Ga]Ga-RM2 is a well-established radiotracer for PET imaging of GRPr, and [177L...

(This article belongs to the Topic Prostate Cancer: Symptoms, Diagnosis & Treatment - 2nd Volume)
  • Article
  • Open Access
214 Views
29 Pages

ENO1 Is More Abundant than ENO2 on the Surface of Metastatic and Neuroendocrine Prostate Cancer Cells and Upregulated in High-Risk Prostate Tumors

  • Krystal R. Santiago,
  • Alfonso M. Durán,
  • Lemti M. Nyirendah,
  • Julia Soliz and ,
  • Ann Morcos,
  • Adelaide V. Makamure,
  • Nathaly P. Manrique,
  • Kathleen Escobar-Acuña,
  • Kristen Whitley and
  • Carlos A. Casiano
  • + 9 authors+ 4 authors

29 October 2026

Metastatic castration-resistant prostate cancer (mCRPC) remains lethal, and lineage plasticity drives a subset of tumors to neuroendocrine prostate cancer (NEPC), most often treatment-emergent (t-NEPC). Prostate-specific membrane antigen (PSMA), the...

(This article belongs to the Special Issue Molecular Mechanisms and Treatments of Prostate Cancer)
  • Article
  • Open Access
966 Views
22 Pages

Development and Characterization of the PSMA-Expressing CT26-PSMA Cell Line as a Rapid Preclinical Platform for 68Ga-Labeled PSMA-Targeted Radioconjugates

  • Aleksandr S. Lunev,
  • Kristina A. Petrosova,
  • Marat G. Rakhimov,
  • Anastasiia A. Uspenskaia and ,
  • Aleksey E. Machulkin,
  • Ipatii S. Malakhov,
  • Olga A. Shashkova,
  • Marina P. Samoilovich,
  • Alexandra E. Zakharkina and
  • Anton A. Larenkov
  • + 5 authors+ 0 author

19 August 2026

Preclinical models play a critical role in the development of PSMA-targeted radiopharmaceuticals for prostate cancer. However, many existing models have practical limitations, including slow tumor growth, low engraftment rates, and restricted availab...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
6 Citations
4,671 Views
16 Pages

Vesicles Secreted by Renal Cell Carcinoma Cells Cause Vascular Endothelial Cells to Express PSMA and Drive Tumor Progression

  • Ryuta Watanabe,
  • Keito Kagimoto,
  • Mami Chosei,
  • Tomohisa Sakaue and ,
  • Mie Kurata,
  • Noriyoshi Miura,
  • Riko Kitazawa,
  • Tadahiko Kikugawa,
  • Shigeki Higashiyama and
  • Takashi Saika
  • + 5 authors+ 0 author

22 January 2025

Prostate-specific membrane antigen (PSMA) protein expression is induced during prostate cancer progression and metastasis. Recently, we reported that PSMA-positive vesicles released by prostate cancer cell lines enhanced vascular endothelial cell ang...

(This article belongs to the Section Cell Signaling)
  • Article
  • Open Access
7 Citations
2,617 Views
14 Pages

The Expression Patterns and Implications of MALAT1, MANCR, PSMA3-AS1 and miR-101 in Esophageal Adenocarcinoma

  • Athanasios Syllaios,
  • Maria Gazouli,
  • Michail Vailas,
  • Konstantinos S. Mylonas and ,
  • Stratigoula Sakellariou,
  • Stavros Sougioultzis,
  • Ioannis Karavokyros,
  • Theodoros Liakakos and
  • Dimitrios Schizas
  • + 4 authors+ 0 author

Esophageal adenocarcinoma (EAC) is a malignant tumor with poorly understood molecular mechanisms. This study endeavors to elucidate how the long non-coding RNAs (lncRNAs) MALAT1, MANCR and PSMA3-AS1, as well as the microRNA miR-101, exhibit specific...

(This article belongs to the Special Issue Advanced Molecular Research in Tumors)
  • Article
  • Open Access
4 Citations
4,160 Views
12 Pages

Enhancing Prostate Cancer Staging: Association of 68Ga-PSMA PET/CT Imaging with Histopathological Grading in Treatment-Naive Patients

  • Oleksii Pisotskyi,
  • Piotr Petrasz,
  • Piotr Zorga,
  • Marcin Gałęski and ,
  • Pawel Szponar,
  • Katarzyna Brzeźniakiewicz-Janus,
  • Tomasz Drewa,
  • Krzysztof Kaczmarek,
  • Michał Cezary Czarnogórski and
  • Jan Adamowicz
  • + 5 authors+ 0 author

18 October 2024

Objective: This study aimed to evaluate the correlation between 68Ga-PSMA uptake in PSMA PET/CT in primary prostate cancer (PC) and its histopathological grading (Gleason score and ISUP grade). Additionally, we compared preoperative biopsy histopatho...

(This article belongs to the Special Issue Advances in the Management of Pelvic Tumors)
  • Article
  • Open Access
20 Citations
5,570 Views
18 Pages

The Potential of PSMA as a Vascular Target in TNBC

  • Amelie Heesch,
  • Lars Ortmanns,
  • Jochen Maurer,
  • Elmar Stickeler and ,
  • Sabri E. M. Sahnoun,
  • Felix M. Mottaghy and
  • Agnieszka Morgenroth
  • + 2 authors+ 0 author

8 February 2023

Recent studies proving prostate-specific membrane antigen (PSMA) expression on triple-negative breast cancer (TNBC) cells and adjacent endothelial cells suggest PSMA as a promising target for therapy of until now not-targetable cancer entities. In th...

(This article belongs to the Collection Emerging Cancer Target Genes)
  • Article
  • Open Access
57 Citations
6,019 Views
19 Pages

Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer

  • Chung-Chieh Chiao,
  • Yen-Hsi Liu,
  • Nam Nhut Phan,
  • Nu Thuy An Ton and ,
  • Hoang Dang Khoa Ta,
  • Gangga Anuraga,
  • Do Thi Minh Xuan,
  • Fenny Fitriani,
  • Elvira Mustikawati Putri Hermanto and
  • Tzu-Jen Kao
  • + 12 authors+ 7 authors

27 November 2021

The complexity of breast cancer includes many interacting biological processes, and proteasome alpha (PSMA) subunits are reported to be involved in many cancerous diseases, although the transcriptomic expression of this gene family in breast cancer s...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
30 Citations
9,370 Views
17 Pages

Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells

  • Ulrich Sommer,
  • Tiziana Siciliano,
  • Celina Ebersbach,
  • Alicia-Marie K. Beier and ,
  • Matthias B. Stope,
  • Korinna Jöhrens,
  • Gustavo B. Baretton,
  • Angelika Borkowetz,
  • Christian Thomas and
  • Holger H. H. Erb
  • + 5 authors+ 0 author

18 January 2022

Prostate-specific membrane antigen (PSMA) is an essential molecular regulator of prostate cancer (PCa) progression coded by the FOLH1 gene. The PSMA protein has become an important factor in metastatic PCa diagnosis and radioligand therapy. However,...

(This article belongs to the Special Issue PSMA in Prostate Cancer)
  • Review
  • Open Access
18 Citations
8,935 Views
17 Pages

PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues

  • Seiji Hoshi,
  • Kei Yaginuma,
  • Satoru Meguro,
  • Akifumi Onagi and ,
  • Kanako Matsuoka,
  • Junya Hata,
  • Yuichi Sato,
  • Hidenori Akaihata,
  • Masao Kataoka and
  • Yoshiyuki Kojima
  • + 7 authors+ 2 authors

1 August 2023

Theranostics (therapy + diagnosis) targeting prostate-specific membrane antigen (PSMA) is an emerging therapeutic modality that could alter treatment strategies for prostate cancer. Although PSMA-targeted radioligand therapy (PSMA-RLT) has a highly t...

(This article belongs to the Special Issue Radiotherapy for Genitourinary Cancer)
  • Article
  • Open Access
7 Citations
3,067 Views
19 Pages

MSTN Regulates Bovine Skeletal Muscle Satellite Cell Differentiation via PSMA6-Mediated AKT Signaling Pathway

  • Tengxia Ma,
  • Meiling Miao,
  • Xiangquan Liu,
  • Linlin Zhang and ,
  • Yiwen Guo,
  • Xin Li,
  • Xiangbin Ding,
  • Hong Guo and
  • Debao Hu
  • + 4 authors+ 0 author

MSTN has been used as a candidate gene in the genetics, breeding, and improvement of animal breeds. However, the possible mechanism by which the MSTN gene regulates muscle development through PSMA6 is not well understood. Previous methylome and trans...

(This article belongs to the Section Molecular Endocrinology and Metabolism)
  • Article
  • Open Access
26 Citations
3,752 Views
23 Pages

Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?

  • Sabine Wächter,
  • Pietro Di Fazio,
  • Elisabeth Maurer,
  • Jerena Manoharan and ,
  • Corinna Keber,
  • Andreas Pfestroff,
  • Damiano Librizzi,
  • Detlef K. Bartsch,
  • Markus Luster and
  • Friederike Eilsberger
  • + 5 authors+ 0 author

14 November 2021

Several studies have demonstrated an expression of the prostate-specific membrane antigen (PSMA) in the cancer-related neovasculature of thyroid malignancies. Due to the poor prognosis and limited therapeutic options for patients with anaplastic (ATC...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
30 Citations
10,052 Views
24 Pages

More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond

  • Anniina Hyväkkä,
  • Verneri Virtanen,
  • Jukka Kemppainen,
  • Tove J. Grönroos and ,
  • Heikki Minn and
  • Maria Sundvall
  • + 1 author+ 0 author

7 May 2021

Prostate cancer is the second most common cancer type in men globally. Although the prognosis for localized prostate cancer is good, no curative treatments are available for metastatic disease. Better diagnostic methods could help target therapies an...

(This article belongs to the Special Issue Diagnosis of Prostate Cancer)
  • Review
  • Open Access
71 Citations
12,255 Views
21 Pages

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research

  • Eline A.M. Ruigrok,
  • Wytske M. van Weerden,
  • Julie Nonnekens and
  • Marion de Jong

Prostate specific membrane antigen (PSMA) has become a major focus point in the research and development of prostate cancer (PCa) imaging and therapeutic strategies using radiolabeled tracers. PSMA has shown to be an excellent target for PCa theranos...

(This article belongs to the Special Issue Targeted Radionuclide Tumor Therapy)
  • Article
  • Open Access
1 Citations
3,459 Views
15 Pages

Improved Prostate-Specific Membrane Antigen (PSMA) Stimulation Using a Super Additive Effect of Dutasteride and Lovastatin In Vitro

  • Aleksandar Kuzmanov,
  • Souzan Salemi,
  • Florian A. Schmid,
  • Irene A. Burger and ,
  • Daniel Eberli and
  • Benedikt Kranzbühler
  • + 1 author+ 0 author

2 August 2023

Prostate-specific membrane antigen (PSMA)-based imaging improved the detection of primary, recurrent and metastatic prostate cancer. However, in certain patients, a low PSMA surface expression can be a limitation for this promising diagnostic tool. P...

(This article belongs to the Special Issue Advances in Prostate Cancer Diagnostics and Therapy)
  • Article
  • Open Access
10 Citations
5,033 Views
21 Pages

PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates

  • Bing Xu,
  • Fei Zhou,
  • Meng-Meng Yan,
  • De-Sheng Cai and ,
  • Wen-Bo Guo,
  • Yu-Qin Yang,
  • Xiao-Hui Jia,
  • Wen-Xi Zhang,
  • Tong Li and
  • Hai-Min Lei
  • + 7 authors+ 2 authors

19 October 2018

Clinical applications of camptothecin (CPT) have been heavily hindered due to its non-targeted toxicity, active lactone ring instability, and poor water solubility. Targeted drug delivery systems may offer the possibility to overcome the above issues...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
11 Citations
4,362 Views
19 Pages

Use of Glycoproteins—Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer

  • Satish Sharma,
  • Katherine Cwiklinski,
  • Donald E. Sykes,
  • Supriya D. Mahajan and ,
  • Kent Chevli,
  • Stanley A. Schwartz and
  • Ravikumar Aalinkeel
  • + 2 authors+ 0 author

30 May 2022

Galectins and prostate specific membrane antigen (PSMA) are glycoproteins that are functionally implicated in prostate cancer (CaP). We undertook this study to analyze the “PSMA-galectin pattern” of the human CaP microenvironment with the...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
58 Citations
8,662 Views
15 Pages

In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles

  • Yunkai Zhu,
  • Ying Sun,
  • Yaqing Chen,
  • Weiyong Liu and ,
  • Jun Jiang,
  • Wenbin Guan,
  • Zhongyang Zhang and
  • Yourong Duan
  • + 3 authors+ 0 author

28 April 2015

The prostate specific membrane antigen (PSMA) is broadly overexpressed on prostate cancer (PCa) cell surfaces. In this study, we report the synthesis, characterization, in vitro binding assay, and in vivo magnetic resonance imaging (MRI) evaluation o...

(This article belongs to the Special Issue Magnetic Nanoparticles 2015)
  • Article
  • Open Access
168 Views
16 Pages

Dynamics of Circulating Tumor Cell Subsets Defined by PSMA and EpCAM Predict Survival in Metastatic Castration-Resistant Prostate Cancer Patients Treated with 177Lu-PSMA-617

  • Madeline J. Lee,
  • Lauren Yu,
  • Nicholas A. Zorko,
  • Scott M. Dehm and ,
  • Justin Hwang,
  • Justin M. Drake,
  • Emmanuel S. Antonarakis and
  • Ali T. Arafa
  • + 3 authors+ 0 author

11 November 2026

Background: 177Lu-PSMA-617 radioligand treatment represents a major advancement in the management of metastatic castration-resistant prostate cancer (mCRPC), but key questions remain about tumor cell dynamics and evolution in patients who have r...

(This article belongs to the Special Issue New Insights in Urologic Oncology: Immune and Tumor Antigen Targeting Approaches)
  • Article
  • Open Access
4 Citations
2,312 Views
14 Pages

Evaluating the Potential of PSMA Targeting in CNS Tumors: Insights from Large-Scale Transcriptome Profiling

  • Adam Kraya,
  • Komal Rathi,
  • Run Jin,
  • Varun Kesherwani and ,
  • Adam C. Resnick,
  • Phillip B. Storm and
  • Ali Nabavizadeh
  • + 2 authors+ 0 author

6 April 2025

Background/Objectives: Prostate-specific membrane antigen (PSMA) is a well-established target in prostate cancer therapy that has shown potential as a theranostic target across non-central nervous system (CNS) and CNS tumor types. We aimed to investi...

(This article belongs to the Special Issue Molecular Pathology of Brain Tumors)
  • Article
  • Open Access
22 Citations
5,481 Views
19 Pages

Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001

  • Vilde Yuli Stenberg,
  • Anna Julie Kjøl Tornes,
  • Hogne Røed Nilsen,
  • Mona-Elisabeth Revheim and ,
  • Øyvind Sverre Bruland,
  • Roy Hartvig Larsen and
  • Asta Juzeniene
  • + 2 authors+ 0 author

3 June 2022

This study aimed to determine the influence of cellular PSMA expression, radioligand binding and internalization, and repeated administrations on the therapeutic effects of the PSMA-targeting radioligand 212Pb-NG001. Cellular binding and internalizat...

(This article belongs to the Special Issue Prostate Cancer Therapy)
  • Article
  • Open Access
27 Citations
3,388 Views
8 Pages

PSMA-PET/CT in Patients with Recurrent Clear Cell Renal Cell Carcinoma: Histopathological Correlations of Imaging Findings

  • Falk Gühne,
  • Philipp Seifert,
  • Bernhard Theis,
  • Matthias Steinert and ,
  • Martin Freesmeyer and
  • Robert Drescher
  • + 1 author+ 0 author

PET/CT with prostate-specific membrane antigen (PSMA)-targeted tracers has been used in the diagnosis and staging of patients with clear cell renal cell carcinoma (ccRCC). For ccRCC primary tumors, PET parameters were shown to predict histologic grad...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
884 Views
32 Pages

[225Ac]Ac-iPSMA Radiopharmaceuticals for Targeted Alpha Therapy: Design, Synthesis, and Preclinical Evaluation

  • Daniel García-Arce,
  • Myrna Luna-Gutiérrez,
  • Pedro Cruz-Nova,
  • Abraham Vidal-Limon and ,
  • Nallely Jiménez-Mancilla,
  • Liliana Aranda-Lara,
  • Erika Azorín-Vega,
  • Enrique Morales-Avila,
  • Paola Rodríguez-López and
  • Blanca Ocampo-García
  • + 7 authors+ 2 authors

31 August 2026

Prostate-specific membrane antigen (PSMA) is a validated theranostic target with clinical relevance extending beyond prostate cancer to PSMA-expressing neovasculature in solid tumors. Despite the success of 177Lu-PSMA therapy, a significant proportio...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
3 Citations
4,024 Views
14 Pages

Synthesis and Preclinical Evaluation of Two Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeted Tracers with 2-Nal-Containing PSMA-Targeted Pharmacophore and Pyridine-Based FAP-Targeted Pharmacophore

  • Arsyangela Verena,
  • Helen Merkens,
  • Chao-Cheng Chen,
  • Devon E. Chapple and ,
  • Lei Wang,
  • Shreya Bendre,
  • Antonio A. W. L. Wong,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 4 authors+ 0 author

9 February 2024

Some bispecific radiotracers have been developed to overcome the limitations of monospecific tracers and improve detection sensitivity for heterogeneous tumor lesions. Here, we aim to synthesize two bispecific tracers targeting prostate-specific memb...

(This article belongs to the Special Issue Advance in Radiochemistry)
  • Review
  • Open Access
14 Citations
4,000 Views
16 Pages

PSMA Theranostics in Prostate Cancer and Beyond: Current and Future Perspectives

  • Kieran Sandhu,
  • David Chen,
  • David Hennes,
  • Declan G. Murphy and ,
  • Nathan Lawrentschuk and
  • Marlon Perera
  • + 1 author+ 0 author

20 November 2025

Prostate-specific membrane antigen (PSMA) is a type II transmembrane glycoprotein that has become central to prostate cancer (PCa) diagnostics and treatment. Beyond its enzymatic role in folate and glutamate metabolism, PSMA is upregulated in advance...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
26 Citations
4,921 Views
14 Pages

Head-to-Head Comparison of [18F]PSMA-1007 and [18F]FDG PET/CT in Patients with Triple-Negative Breast Cancer

  • Natalia Andryszak,
  • Daria Świniuch,
  • Elżbieta Wójcik,
  • Rodryg Ramlau and ,
  • Marek Ruchała and
  • Rafał Czepczyński
  • + 1 author+ 0 author

4 February 2024

Background: Triple-negative breast cancer (TNBC) exhibits high aggressiveness and a notably poorer prognosis at advanced stages. Nuclear medicine offers new possibilities, not only for diagnosis but also potentially promising therapeutic strategies....

(This article belongs to the Special Issue Triple Negative Breast Cancer Therapy Resistance and Metastasis)
  • Article
  • Open Access
14 Citations
3,396 Views
13 Pages

Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R

  • Romain Schollhammer,
  • Marie-Laure Quintyn Ranty,
  • Henri de Clermont Gallerande,
  • Florine Cavelier and ,
  • Ibai E. Valverde,
  • Delphine Vimont,
  • Elif Hindié and
  • Clément Morgat
  • + 3 authors+ 0 author

18 April 2023

The imaging of Prostate-Specific Membrane Antigen (PSMA) is now widely used at the initial staging of prostate cancers in patients with a high metastatic risk. However, its ability to detect low-grade tumor lesions is not optimal. Methods: First, we...

(This article belongs to the Special Issue Prostate Cancer Progression)
  • Review
  • Open Access
8 Citations
3,978 Views
12 Pages

RadioLigand Therapy with [177Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France

  • Marie Terroir,
  • Chloé Lamesa,
  • Mehdi Krim,
  • Lavinia Vija and ,
  • Jean-Sébastien Texier,
  • Thibaut Cassou-Mounat,
  • Jean-Pierre Delord,
  • Delphine Vallot and
  • Frédéric Courbon
  • + 4 authors+ 0 author

Salivary gland cancers are rare tumors comprising a large group of heterogeneous tumors with variable prognosis. Their therapeutic management at a metastatic stage is challenging due to the lack of therapeutic lines and the toxicity of treatments. [1...

(This article belongs to the Section Radiopharmaceutical Sciences)
  • Article
  • Open Access
14 Citations
5,122 Views
15 Pages

Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [68Ga]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation

  • Fanny Lundmark,
  • Ayman Abouzayed,
  • Sara S. Rinne,
  • Vasiliy Timofeev and ,
  • Nadezhda Sipkina,
  • Maria Naan,
  • Anastasia Kirichenko,
  • Maria Vasyutina,
  • Daria Ryzhkova and
  • Anna Orlova
  • + 7 authors+ 2 authors

10 January 2023

The development of radioligands targeting prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRPR) has shown promising results for the imaging and therapy of prostate cancer. However, studies have shown that tumors and...

(This article belongs to the Special Issue Diagnostic and Treatment for Three Urological Cancers: Bladder Cancer, Kidney Cancer and Prostate Cancer)
  • Article
  • Open Access
11 Citations
6,112 Views
19 Pages

Synthesis and Evaluation of 99mTc-Tricabonyl Labeled Isonitrile Conjugates for Prostate-Specific Membrane Antigen (PSMA) Image

  • Nadeem Ahmed Lodhi,
  • Ji Yong Park,
  • Kyuwan Kim,
  • Mi Kyung Hong and ,
  • Young Joo Kim,
  • Yun-Sang Lee,
  • Gi Jeong Cheon,
  • Keon Wook Kang and
  • Jae Min Jeong
  • + 4 authors+ 0 author

Prostate-specific membrane antigen (PSMA) is a biomarker expressed on the surface of prostate cancer (PCa). In an effort to improve the detection and treatment of PCa, small urea-based PSMA inhibitors have been studied extensively. In the present stu...

(This article belongs to the Special Issue Advanced Applications of Technetium Chemistry)
  • Article
  • Open Access
14 Citations
4,493 Views
14 Pages

An Albumin-Binding PSMA Ligand with Higher Tumor Accumulation for PET Imaging of Prostate Cancer

  • Ya’nan Ren,
  • Teli Liu,
  • Chen Liu,
  • Xiaoyi Guo and ,
  • Feng Wang,
  • Hua Zhu and
  • Zhi Yang
  • + 2 authors+ 0 author

22 April 2022

Prostate-specific membrane antigen (PSMA) is an ideal target for the diagnosis and treatment of prostate cancer. Due to the short half-life in blood, small molecules/peptides are rapidly cleared by the circulatory system. Prolonging the half-life of...

(This article belongs to the Special Issue Molecular Imaging in Oncology: Radiopharmaceuticals for PET and SPECT 2022)
  • Review
  • Open Access
130 Citations
26,852 Views
17 Pages

Over 90% of prostate cancers over-express prostate specific membrane antigen (PSMA) and these tumor cells may be accurately targeted for diagnosis by 68Ga-PSMA-positron emission tomography/computed tomography (68Ga-PSMA-PET/CT) imaging. This novel mo...

(This article belongs to the Section Medical Imaging and Theranostics)

of 5